Anatomic Pathology Market Size & Share 2022 | Upcoming Trends, Top Players and Regional Outlook Till 2030

The size of the worldwide Anatomic Pathology Market was estimated at US$ 32.5 million in 2022 and is projected to surpass US$ 61.1 million by the end of 2030, growing at a strong CAGR of 8.2% between 2022 and 2030.

The size of the worldwide Anatomic Pathology Market was estimated at US$ 32.5 million in 2022 and is projected to surpass US$ 61.1 million by the end of 2030, growing at a strong CAGR of 8.2% between 2022 and 2030. The increasing use of anatomic pathology in illness diagnosis and the development of new drugs is what is fueling the growth of the worldwide anatomical pathology market.

The global Anatomic Pathology Market is set to reach US$ 61.1 Mn in revenues by 2030, according to a new market study by ESOMAR-certified market research firm, Future Market Insights (FMI).

The anatomic pathology market is subject to integrating medical informatics standards to meet specific healthcare requirements by curtailing costs and improvising on efficiency.

Pathology laboratories are on the verge of renovation as new-fangled disease diagnostic models are making a beeline therein.

Get Full Access: https://www.futuremarketinsights.com/reports/anatomic-pathology-market?utm_source=4018419utm_medium=Sanket

As of now, lymphoma, breast cancer, colorectal cancer, prostate cancer, cervical cancer, and lung cancer are a part of anatomical pathology.

Key Takeaways

  • The instruments are subject to technological advances, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2022 and 2030
  • Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents
  • Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination
  • Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers

" The anatomic pathology market is witnessing a continuous upswing on the part of biomarkers. This factor is expected to propel the development of the anatomical pathology market "  -  says the FMI analyst.

Key Participant Insights

The key market players are focusing on technological upgrades and expansion strategies to keep themselves fiercely competitive.

For example –

  • In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.
  • In Jan 2019, Quest Diagnostics announced the completion of the acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest's infectious disease testing services.
  • In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.

The other players in the veterinary imaging market include

  • Laboratory Corporation of America Holdings
  • Sakura Finetek USA, Inc.
  • F.Hoffmann-La Roche AG
  • Cardinal Health, Inc.
  • BioGenex
  • NeoGenomics
  • Agilent Technologies

The US continues to be one of the leading markets for anatomic pathology market globally. Strong presence of some of the leading players, combined with relatively easier funding for RD will drive the US anatomical pathology market during the assessment period.

The European anatomical pathology market is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.

Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global anatomic pathology market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on anatomic pathology market on the basis of product services type (Instruments (Microtomes Cryostat, Tissue processors, Automatic Stainers, and Other products), consumables (Reagents Antibodies, Probes Kits, and Others), application (Disease Diagnosis, Drug Discovery and Development, and Others), and services (histopathology, cytopathology)) across seven geographies.

Key Segments of Anatomic Pathology Industry Survey

Anatomic Pathology Market by Product Service:

  • Anatomic Pathology Instruments
  • Anatomic Pathology Consumables
  • Anatomic Pathology Services

Anatomic Pathology Market by Application:

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

Anatomic Pathology Market by End User:

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Sanket Badgujar

20 Blog Paylaşım

Şərh